Prior information notice
This notice is a call for competition
Section I: Contracting
authority
I.1) Name and addresses
Porton Biopharma Ltd
Manor Farm Road, Porton Down
Salisbury
SP4 0JG
UK
E-mail: Jeff.Pike@portonbiopharma.com
NUTS: UKK
Internet address(es)
Main address: https://phe.bravosolution.co.uk
I.3) Communication
Access to the procurement documents is restricted. Further information can be obtained at:
https://phe.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://phe.bravosolution.co.uk
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Pharmaceutical Manufacturing
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Services
II.1.4) Short description
Porton Biopharma Ltd would like to invite expressions of interest from contract manufacturers that have the capability to formulate, fill into vials and freeze dry a biological drug substance for United States and rest of the world distribution.
The potential manufacturer must be experienced in pharmaceutical manufacturing under sterile conditions and be open to audit. A good company track record is essential.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
00
II.2.4) Description of the procurement
Porton Biopharma Ltd would like to invite expressions of interest from contract manufacturers that have the capability to formulate, fill into vials and freeze dry a biological drug substance for United States and rest of the world distribution.
The potential manufacturer must be experienced in pharmaceutical manufacturing under sterile conditions and be open to audit. A good company track record is essential.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Please note this procurement will require bidders to sign and be constrained by a Confidentiality Disclosure Agreement.
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
III.2.3) Information about staff responsible for the performance of the contract
Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Restricted procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of expressions of interest
Date:
10/07/2018
Local time: 17:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
Section VI: Complementary information
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
VI.4) Procedures for review
VI.4.1) Review body
Porton Biopharma Ltd
Salisbury
UK
VI.5) Date of dispatch of this notice
04/06/2018